Database

Startups

Taiwan Universe BioMedicine Inc.

Taiwan Universe BioMedicine Inc.

Selected as a startup company by FINDIT Matchmaking in the past two years
Update:2025/08/19
Industries
Main Industry
Biotechnology
Main Product/Service
Main Product
Innovative platform of enterovirus and influenza VLP vaccines
Promising option to combat viruses mutation
Provide a broad-spectrum prevention with better immunogenicity
Enable faster scaling-up
Founded Year
2023
Unified Business No.
94247033
Status
Active
Number of Employees
0
Total Paid-in Capital
45,000,000 (NT$)
Year of establishment, company status, responsible person, paid-in capital amount, and registered address are sourced from the "Commerce Industrial Services Portal, Department of Commerce, Ministry of Economic Affairs.
Location of Company
Taiwan , Taipei City
Introduction
Dr. Min-Shi Lee has more than 30 years experiences in vaccine research and development including 6 years R&D in USA vaccine company, and several national vaccine development projects of enterovirus, influenza H5N1, H7N9 and seasonal influenza. To strengthen and grow Taiwan’s vaccine business, Dr. Min-Shi Lee’s group has established a start-up company for developing bivalent enterovirus vaccines and seasonal influenza virus-like particle (VLP) vaccines and also expend to more diseases area through this innovative technology platforms.

PhD, Oxford University, UK
MPH, National Taiwan University
Investigator, NHRI, Taiwan (2005~)
Scientist, Aviron/Medimmune (1999~2005)
NIPM (former CDC), Taiwan (1993~1998)
>30 years for vaccine research including measles, JEV, influenza (FluMist licensed in USA) , PIV3, and EV71 (licensed in Taiwan)
Built Asia-Pacific Network for Enterovirus Surveillance (APNES)



More ↓

Similar Companies

U-NEURON BIOMEDICAL INC.

State-level Storage Equipment and Technology
U-NEURON BIOMEDICAL is devoted to the development of stem cell isolation, storage and clinical applications. It owns the Patent on the Technology of Isolation and Culture of Amniotic Fluid Stem Cell, and has signed a service contract on the support of cell operation laboratory facilities and instruments with Bioresource Collection and Research Center; meanwhile, it has completed the pre-clinical trial for treatment of urinary incontinence with amniotic fluid stem cells with National Yang-Ming University. Recently, U-NEURON BIOMEDICAL has cooperated with Linkou Chang Gung Memorial Hospital on clinical trials of a rare disease – osteogenesis imperfecta (glass doll), and continues the research and development of the latest cell treatment and applications. Through continuous research, U-NEURON BIOMEDICAL carries out manufacturing that meets clinical specifications, creates new stem cell therapy technologies to fill current medical gaps, and popularizes stem cell technology and cell therapy products through professional technology development and medical research, creating real value of regenerative medicine and a better life for humankind.